PMDA
- Application: Ryzodeg
- Local brand name: Ryzodeg
- Status: approved
Ryzodeg® (Ryzodeg®) regulatory status in Japan.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA has authorised it.
Novo Nordisk A/S is the originator. The local marketing authorisation holder may differ — check the official source linked above.